Desktop Site
|
26 Apr 24 | 12:18
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,209.64
-129.80
-0.17 %
Corporate Announcement
Security Code
524804
Company
Aurobindo Pharma Ltd
Exchange Received Time
26/02/2020 09:05:28
Exchange Disseminated Time
26/02/2020 09:05:35
Time Taken
00:00:07
Update On US FDA Inspection At Our Unit VIII - Reg., |
2/26/2020 9:05:28 AM
Further to our intimation dated November 6th, 2019 with regard to the USFDA inspection of Unit VIII, API manufacturing facility at Gaddapotharam, Hyderabad of the company, we would like to inform that the Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAI) status from USFDA.
Attachment
<< Back
Recently Viewed